Money Info Show

Investment News Show

Money Info Show Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show


Use this Link To Watch The Show:

Be On The Air With Us
Call In Your Questions

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

The show is broadcast live on the internet and on the air  from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast 

Money Info is hosted by investing experts Mike King and Charles Moskowitz together with radio broadcasting professional Greg Wyatt.

Watch Money Info

Investment News Show Replays

August 4, 2015 Show

The show features a live interview with:

Immune Therapeutics Inc.

(Stock Symbol: IMUN),

CEO Noreen Griffin


Dr Ellenby

small cap medical stock

Visit The Corporate Site —

See Corporate Investors Information and stock quote page:
Click Here

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.

Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.

Small Cap Stocks to Buy August 2015

Medical Stocks to Buy August 2015

The biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using our patented immunotherapy.

Their Products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.

The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.

undervalued medical Stocks to Buy August 2015

Small Cap Medical Stock News

Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.

Immune Therapeutics Inc – Lodonal™ an Adjunct Immune Therapy for Treatment of Patients with HIV/AIDS

ORLANDO, Fla. and DUBLIN, May 4, 2015/PRNewswire/ — Immune Therapeutics Inc (IMUN) “Immune Therapeutics”, through its fully owned subsidiary, TNI Biotech International, today announced the dosing of the first patient with Lodonal™ (Once-daily OralTreatment) for the 90-Day bridging clinical trial of Immune Therapeutics’ proprietary patented therapy (Lodonal™) as an adjunct  treatment for HIV/AIDS and opportunistic infections. — See More

best Stocks to Buy August 2015

Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News


Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News

Small cap stocks to buy

Stocks to Buy August 2015 on Investment News Show


July 28, 2015 Show

Free Call App on

Investment News Show

The July 28th show features a live interview with

Bryan Hertz, Chairman, CEO and Co-founder

See Corporate Site:

Skype alternative

Voxox is an innovator in unified cloud communication solutions for consumers and businesses.


For consumers and its operator partners, Voxox delivers cutting-edge mobile and desktop applications that integrate voice, video, messaging, fax, media sharing and more.

free to anywhere in the world

Free or cheap calls to anywhere in the world

For businesses, Voxox provides an extensive suite of carrier-grade business phone solutions, including hosted IP-PBX, SIP Trunking, a wide array of wholesale services, such as high volume SMS, and the company’s new virtual PBX service, Cloud Phone.

free call app

Free Call App

The foundation of the company’s offerings is its award-winning unified communications platform in the cloud, which enables the company and its customers to build powerful, scalable applications and services.

Founded in 2006, Voxox is headquartered in San Diego.

free calls on line

Skype alternative

Bryan Hertz, Voxox Chairman, CEO and Co-founder

Bryan is a successful entrepreneur, bringing more than 20 years of experience in building companies and management teams, raising capital and driving technology innovation for Fortune 500 banks, insurance companies and data processing facilities.

Bryan entered the telecom industry in 2006 and created Voxox to fulfill his vision to unify personal and business communications on a global basis.

Today award-winning Voxox solutions are used in over 200 countries by consumers and businesses.

July 21, 2015 Show

The July 21, 2015 show featured a live interview with

Michael Shea, CEO


Barbara Carroll, VP Development of

International Star, Inc.

Stock Symbol: ILST

Undervalued Gold Mining Stockss

See Corporate Site:

Read the Investors Fact Sheet — Click Here

Get ILST stock quote from Yahoo Finance — Click Here


Listen To Show Replay Part 1 (beginning of show):


Listen To Part 2 Replay with Michael Shea, CEO, Chairman And

Barbara Carroll, Director, Vice President of Project Development

International Star, Inc. live interview:


Small Cap USA Gold Mining Stocks

International Star is a US company with five unpatented lode claims totaling approximately 100 acres the “Van Demeen”). The Company has also located 18 unpatented lode claims in the area surrounding the Van Demeen which have been staked and recorded with the U.S. Bureau of Land Management and the Mohave County Recorder.

Undervalued Gold Mining Stocks

Mining Deposits Block Model

International Star has a attractive and prospective land package near the Black Mountains of Arizona.

Arizona Gold Mining Stocks To BuyArizona Gold Mining Stocks To Buy

International Star primary focus is to bring the Van Demeen gold project into production within 12-15 months.

USA Gold Mining Stocks

Small Cap USA Gold Mining Stocks

The board and management of International Star are experienced mine operators and developers with experience from some of the world’s largest, most successful gold companies with a proven ability to develop and grow production for the benefit of the company’s shareholders.

Undervalued Gold Mining Stocks 

gold mining stocks

Small cap gold mining stocks to buy

July 14, 2015 Show

Money Info

Investment News Show

The July 14, 2015 show featured a live interview with

RMS Medical Products, Inc.

(Stock Symbol: REPR)

President and Chairman of the Board

Andrew Sealfon

Listen to a replay of Part 1 of the show:


Listen to a replay of Part 2 of the show with  Andrew Sealfon RMS Medical Products interview:


Small Cap Medical Stocks

RMS Medical Products, Inc.

(Stock Symbol: REPR)

Visit the corporate website:

For REPR stock quotes, trading charts and their latest news releases visit this Yahoo Finance link:

 Undervalued Small Cap Medical Stocks

under valued medical products stock

REPR continues to increase revenues and create organic growth by using the cash from revenues to hire more staff, increase research efforts and expand marketing and sales.


REPR Annual Revenue and Profits Continue To Increase

New health insurance changes are forcing more and more home health care

A sector in which REPR excels.

small cap medical products stock

Medical Growth Stock

RMS Stock has doubled this year already and can double again.

RMS designs, markets, manufactures portable easy to operate infusion devices, including needles and tubing. It is easy to handle by patients.

The Freedom 60 is being marketed in Europe as well as gaining a footing among home-care professionals in America. The RescueVac is used in ambulances and planes for emergency suction.

under valued medical products stock news

Sales for the FREEDOM 60® pump continue to produce spectacular grow.

RMS Medical Products specializes in developing and manufacturing portable medical devices,  understanding that healthcare professionals need products that they can depend on in critical situations – that will work every time. For patients, these products are often profoundly uplifting to their quality of life.

With that in mind, REPR offers products for a wide variety of markets including hospitals, home healthcare, nursing homes and rescue services.

Primary products are: 

FREEDOM60® Syringe Infusion System –  Used for the subcutaneous administration of immune globulin offers safe, controlled pressure and ability to adjust automatically to the flow. The inherently safe pressures used to deliver drugs to patients minimize discomfort, swelling and other complications sometimes found with conventional electric infusion devices. There are additional applications such as the delivery of antibiotics and other drugs. 

RES-Q-VAC® Emergency Suction – Fills a niche in emergency medicine, hospitals, and home care for immediate airway suction when and wherever needed. RES-Q-VAC® has patented filtration to minimize exposure of medical personnel to dangerous pathogens from patients infected with life threatening diseases such as tuberculosis and SARS. Because RES-Q-VAC® provides reliable suction without electric power, it is useful in disasters when the electricity fails.

RMS HIGH-Flo™  Subcutaneous Safety Needle Sets – RMS Successfully introduced this product to the US market during the 2012 fiscal year. Used with the Company’s FREEDOM60® pump or pumps from other manufacturers. The Company has received feedback from some SCIG patients experiencing less pain, less infusion time, and less discomfort when switching to High-Flo™.

 See more product information at

top medical products stock


June 30, 2015 Show

Skin Products Stocks


New Sunscreen Products Stocks on

Investment News Show

The show featured a live interview with

Terry Howlett, 

President & CEO of

Skinvisible, Inc.

Stock Symbol: SKVI

Listen To Show Replay Part 1:


Listen To Show Replay Part 2 With Terry Howlett, Skinvisible CEO Interview:


The Show also featured a live interview with Tim Connolly of Texas Gulf Oil & Gas Inc.  (See site) and business funding and development specialists, Corporate Strategies, Inc. (See Site).

Listen To Show Replay Part 3 With Tim Connolly Oil Industry News Interview:


Corporate Strategies customizes a unique, immediate action plan to address each client’s specific needs. We assemble a team of seasoned professionals with extensive experience in your industry, who are experts in business development, finance, capital raising, operations, project management, due diligence and corporate restructuring services. The Corporate Strategies team is then ready to pursue the successful outcome as defined  by our client.

Texas Gulf Oil and Gas, Inc. (TGOG) is an independent oil and gas company based in Houston,Texas with field offices in Luling,Texas.

  • Our mission is to increase oil and gas production, using both conventional and proprietary enhanced production techniques, in previously proven production areas.
  • Due to the opportunity presented by dramatically lower oil prices, TGOG has begun to acquire and develop a three year target of 5,000+ barrels of oil equivalent (boepd) in shallow well production (approx 6000’ depth and less) per day in long standing production areas throughout Texas


skin products stocks


See Skinvisible Corporate Site — Click Here

Get Skinvisible (SKVI) stock quote, trading chart and latest news from YAHOO finance — Click Here

Skin products stock news

Skinvisible, Inc., through its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc., is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products to treat acne, skin cancers, eczema, fungal infections, inflammation, warts and dermatitis along with sunscreens, anti-aging products, alcohol-free hand sanitizing lotions, pre-surgical preparations, and various other medical treatments using its patented technology Invisicare®. Skinvisible’s primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products.

Skin and Sunscreen Products Stocks 

Skinvisible’s mission is to develop innovative technology and superior topical polymer delivery vehicles designed to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.

It is Skinvisible’s intention to direct its ongoing energies and resources towards the following objectives:

  • To capitalize on licensing opportunities for its Invisicare technology and formulated products to established pharmaceutical, medical, cosmetic, skincare and consumer goods manufacturers.
  • To develop new polymer delivery vehicles designed to create or enhance formulated products for existing and new customers for a variety of applications.
  • To enter into strategic relationships and attract alliances to expand research, development and collaborative product investigations for its patented polymer delivery vehicles and formulations.
  • To increase on-going revenues and profitability from current licensees.
  • To maximize shareholder value.

 Sunscreen Products Stocks

Terry Howlett — President & Chief Executive Officer

Mr. Howlett founded Skinvisible, Inc. in 1998. With over 30 years of entrepreneurial, business management and market initialization experience, he drives and directs the Company’s development and technology vision. He is adept at guiding emerging and publicly traded start-up companies through the stages of capital formation, strategic planning and business growth; specializing in venture capital financing. Mr. Howlett’s diversified background includes senior management, marketing, and sales positions with both established and start-up companies.

Sunscreen Products Stocks

Sunscreen Products Stock NEWS


Skinvisible Inc., (OTCQB: SKVI) through its wholly-owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the official launch of Skinbrella®, a patented sunscreen like no other. Skinbrella meets or exceeds all FDA requirements for a broad-spectrum, 80 minute water-resistant sunscreen.

“With millions of new skin cancer diagnosis each year, sun protection should be a daily lifestyle choice for everyone,” said Mr. Terry Howlett, President of Kintari. “The challenge of course is many sunscreens breakdown when exposed to sunlight or esthetically they are not pleasing. Kintari provides a solution to everyone’s daily sunscreen needs with Skinbrella. Today we are thrilled to announce that Skinbrella; a truly remarkable sunscreen with the patents to prove it, is available on and through our independent distributors and their websites.”

Skinbrella is a broad spectrum, SPF 30 sunscreen made with the Company’s patented topical delivery technology Invisicare®. It provides 80 minutes of water resistance; the highest designation allowed by the FDA. Skinbrella glides on smoothly without any sticky after feel, while still allowing the skin to breath naturally. It meets the requirements to be labeled “broad spectrum”, signifying it provides both UVA and UVB protection.

sunscreen products stock news


Skinvisible Inc., (OTCQB: SKVI) through its wholly owned subsidiary Kintari International Inc., marketer of patented “Youth Renewed” skin care products, is pleased to announce the successful official launch of its network marketing company.

“We are very pleased to announce that our January 15th official launch of Kintari in the USA was very exciting for us and the new distributors that attended from across the US,” said Mr. Terry Howlett, President of Kintari.

The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight the signs of aging. The Kintari YR product line includes a rejuvenating day cream and a renewing night cream. These products have been developed using proven anti-aging ingredients with scientific evidence of their effectiveness at reducing the look of fine lines and wrinkles resulting in youthful looking skin. These potent ingredients are powered by our patented Invisicare® skin delivery technology, providing consumers with unique, effective skincare benefits which cannot be duplicated and our Kintari distributors with products that no other company can offer. Kintari products are truly one of a kind.

skin products undervlaued stocksi


Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) – through its wholly owned subsidiary Kintari International Inc., makers of patented “Youth Renewed” skin care products – is pleased to announce the selection of R. Dean Aldridge in the key role of Master Distributor. Dean will spearhead distributor expansion and development globally.

“We are very pleased to have Dean Aldridge, a world class marketer and sales leader, as our Master Distributor for Kintari,” said Terry Howlett, President of Kintari. “The Master Distributor plays a crucial role in the upward trajectory of the number of distributors that join Kintari and the sales they produce. Dean has exactly the skills and experience to make Kintari a huge success.” He added, “Dean has proven his skills over the past fifteen years in the network marketing industry. He is a multiple award winner and has climbed to the highest level of every company he has been associated with. Dean is often referred to as one of the top recruiters as well as one of the best relationship builders our industry has seen. His expertise has taken him to the top echelons of financial rewards and is touted as one of network marketing’s most distinguished international leaders.”


Investment News Show

Money Info Show

Replay Archives

Hear Replays of

June 2015 to

April 2015 Shows

Click Here


Hear Replays of

March 2015 to

October 2014 Shows

Click Here


Hear Replays of

September 2014 to

July 2014 Shows

Click Here

Hear Replays of

July and June 2014 Shows

Click Here

Hear Replays of

May, April and

March 2014 Shows

Click Here

Hear Replays of

January and February 2014 Shows

Click Here


Hear Replays of

December and November 2013 Shows

Click Here

Hear Replays of October 2013 Shows

Click Here

Hear Replays of September 2013 Shows:

Click Here

Hear Replays of August 2013 Shows

Click Here

June 2013 and July 2013

Money Info Show Replays

Click Here


April 2013 and May 2013

Money Info Show Replays

Click Here


March 2013 and February 2013

Money Info Show Replays

Click Here


January 2013

Money Info Show Recaps

Click Here


November 2012

Money Info Show Replays

Get recaps of November Shows

October 2012

Money Info Show Replays

Get recaps of October Shows


September 2012

Money Info Show Replays

See past show recaps


Money Info

The Princeton Research Money Info Show features where to invest now,

stock market, business, economy and

financial investment news.

Money Info is hosted by Mike King, Charles Moskowitz, Oscar Carboni and K. C. Quintana.


Stock Options Trading Alerts Update:

In order to make more investors aware of the exceptional gains we are producing with our Options Trading Alerts Service we are offering (for a very limited time) free sample trade alerts and sample issues of the Market Strategies Newsletter.

See to get in today.

Money Info

Money Info Investment News Show

Leave a Reply

© 2015 - 2000 Copyrighted - Michael King And Princeton Research, Inc. ALL RIGHTS RESERVED.

Reproduction or distribution of any or all material on this web site or in Princeton Research Market Strategies Newsletters are strictly prohibited without expressed written consent. All content, images and material on this site is protected by International copyright laws.

Disclaimer: Princeton Research, Inc. and its principal J. Michael (Mike) King are professional traders of stocks, options, commodities and other investment instruments. At anytime, Princeton Research, Inc., J. Michael (Mike) King and their affiliates may buy and sell stocks, options, commodities and other investment instruments in their sole discretion and without prior public notice. All viewers are cautioned that trading is highly risky and only persons who can sustain the risk of loss should engage in speculative trading.

This web site is for informational purposes only. No part of this site is to be considered stock solicitation or an offer to buy or sell securities. No investment advice of any kind is to be inferred from this site. This site contains "forward looking statements" as defined by SEC regulations. Opinions expressed are those of Mike King and the Princeton Research staff. Companies mentioned on this site have neither approved nor disapproved this site content. All information shown was obtained from data available on the Internet.

Here at Princeton Research, Inc. it is our policy to provide news, information on and links to featured companies and investment opportunities that we believe have the potential to produce high returns.

Rule 17B Requirements -- Disclosure of Payment for Investor Relations -- Princeton has approximately 2,581,578 shares of AIVN both free and restricted and represents them for investor relations services. Princeton also has about 40,000 shares of TXGE. Princeton is paid $1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton will be engaged by Target Energy Ltd. No contract is currently in place. In the past Princeton Research, Inc. received about $2,500 per month from Lucas Energy, Inc. (LEI). In the past Princeton has been paid for investor relations in the past and has negotiated a contract to be paid 100,000 restricted shares from Leo Motors. In the past Princeton was paid by Baron Energy (BROE) to do investor relations in the amount of 300,000 shares. Princeton has also bought separate shares about 227,600 and owns the shares for its own account. In the past Princeton Research received 550,000 restricted shares from BCLE in exchange for investor relations services. Princeton Research has received 150,000 restricted shares from Skinvisible in exchange for investor relations services. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.

Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to on this site and/or in any e-mailings. Princeton may buy or sell its free-trading shares in companies it represents at any time.

Investment Strategies | How To Invest $10,000 Trading Portfolio | Trading Alerts | How To Invest |
Stocks To Buy | Featured Investments | Services To Inform Investors |
Market Strategies Newsletters | Money Info Investment News Radio Shows |
Where to Invest Your Money Now | Investing Trade Alerts |
Options Trading Strategies | Options Trading Alerts |
Stock Options Trading Alerts | Where To Invest In 2015 |
Mike King | About | Contact |
Text Site Map | ror Site Map | Site Map | XML Site Map

      Push 2 Check

Theme by Anders Norén